All In Biotech

Free tool

FAERS Monitor: Santyl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 101995 or its brand name (Santyl, Collagenase). Reports on generic versions are filed under their own applications.

Reports

1,690

Serious

1,022

60% of reports

Hospitalization

400

Death reported

486

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death388
  • wound complication159
  • drug ineffective120
  • application site pain109
  • off label use68
  • pain64
  • impaired healing61
  • wound59
  • acute kidney injury52
  • chronic kidney disease52
  • nausea48
  • diarrhoea46
  • wound infection46
  • renal failure44
  • wound secretion44

Reports by year received

View as table
YearReports
20111
20121
201321
201414
201550
2016115
2017136
2018171
2019163
202091
202177
2022147
2023112
2024139
2025227
2026225

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,469 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wound complicationSignal159604.6519.490,819
wound secretionSignal44141.4105.55,929
application site painSignal10961.951.66,443
wound infectionSignal4652.539.52,264
woundSignal5926.320.51,411
impaired healingSignal6123.218.11,271
chronic kidney diseaseSignal528.56.5339
deathSignal3885.65.11,526
acute kidney injurySignal524.23.2126
renal failureSignal444.13.1102
pain641.31.04
drug ineffective1201.11.02
off label use681.00.80
diarrhoea460.90.71
nausea480.80.64

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.